Holen Sie sich die Stockscreener-App
11.10
2.29%
-0.26
Alumis Inc Aktie (ALMS) Neueste Nachrichten
Alumis (NASDAQ:ALMS) Shares Down 7.9%What's Next? - MarketBeat
What Alumis (ALMS)'s Envudeucitinib Phase 3 Data and Deepening Losses Means For Shareholders - simplywall.st
Equities Analysts Set Expectations for Alumis Q3 Earnings - MarketBeat
H.C. Wainwright reiterates Alumis stock rating at neutral, $25 target - Investing.com
Venture investor’s big move: Latigo Biotherapeutics (ALMS) lands new 14.5% holder - Stock Titan
Alumis (NASDAQ:ALMS) Lowered to "Strong Sell" Rating by Wall Street Zen - MarketBeat
Alumis' (ALMS) "Neutral" Rating Reaffirmed at HC Wainwright - MarketBeat
Alumis (NASDAQ:ALMS) Shares Gap Down After Earnings Miss - MarketBeat
ALMS Q1 2026 Earnings: Narrower-Than-Expected Loss Slightly Overshadows Share DeclineLong-Term Guidance - Vinanet
Alumis Swings to Q2 Net Loss, Revenue Falls - marketscreener.com
ALMS SWOT Analysis: Financial Challenges and Opportunities Revea - GuruFocus
Alumis (NASDAQ:ALMS) Issues Earnings Results - marketbeat.com
Alumis Q2 Results: EPS Misses Estimate, Sales Fall 37% YoY - scanx.trade
Alumis (ALMS) Posts Q2 Loss; Price-to-Sales Ratio Highlights Mar - GuruFocus
Alumis Inc. (ALMS) reports $235M loss but ends quarter with $502M cash - Stock Titan
Alumis Reports Second Quarter 2026 Financial Results and Highlights Recent Achievements - The Manila Times
Earnings Flash (ALMS) Alumis Inc. Reports Q2 Revenue $1.7M, vs. FactSet Est of $3.5M - marketscreener.com
Earnings Flash (ALMS) Alumis Inc. Reports Q2 Revenue $1.7M, Vs. FactSet Est of $3.5M - Moomoo
California State Teachers Retirement System Raises Stock Position in Alumis Inc. $ALMS - MarketBeat
Alumis Inc. (ALMS) Climbs 1.69% as Biotech Stock Approaches Key Resistance at $27.09Value Area High - vinanet.vn
Alumis (NASDAQ:ALMS) Trading Down 9.6%Should You Sell? - MarketBeat
4 Psoriasis Drug Stocks to Watch During Psoriasis Awareness Month 2026 - The Globe and Mail
Alumis Psoriasis Treatment Shows Leading Skin Clearance Rates - Benzinga
Alumis reports 54% complete skin clearance in psoriasis trial By Investing.com - Investing.com South Africa
Alumis reports 54% complete skin clearance in psoriasis trial - Investing.com
Alumis: Envudeucitinib Shows 54% PASI 100 at 48 Weeks, NDA on Track for 4Q 2026 - TradingView
First Trust Advisors LP Takes $1.46 Million Position in Alumis Inc. $ALMS - MarketBeat
Alumis Inc (ALMS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Alumis Inc. $ALMS Shares Bought by The Manufacturers Life Insurance Company - MarketBeat
Technical Reactions to ALMS Trends in Macro Strategies - Stock Traders Daily
FMR reports 5.5% Alumis Inc (ALMS) stake in Schedule 13G filing - stocktitan.net
Bank of New York Mellon Corp Raises Holdings in Alumis Inc. $ALMS - MarketBeat
Alumis (NASDAQ:ALMS) Insider Jorn Drappa Sells 2,447 Shares of Stock - MarketBeat
Alumis (NASDAQ:ALMS) Insider Sanam Pangali Sells 1,364 Shares of Stock - MarketBeat
Alumis (NASDAQ:ALMS) CFO John Schroer Sells 3,282 Shares - MarketBeat
Alumis (ALMS) CFO sells 3,282 shares in tax-related sell-to-cover trade - Stock Titan
Alumis Inc. (ALMS) officer sells 2,692 shares in tax sell-to-cover trade - Stock Titan
Alumis Inc. (ALMS) CDO sells 2,572 shares to cover RSU taxes - stocktitan.net
Alumis (ALMS) to Post Quarterly Earnings on Wednesday - MarketBeat
Alumis (NASDAQ:ALMS) Given Neutral Rating at HC Wainwright - MarketBeat
Alumis (NASDAQ:ALMS) Trading Down 4.1%Should You Sell? - MarketBeat
Janus Henderson Group PLC Takes $46.79 Million Position in Alumis Inc. $ALMS - MarketBeat
Swiss National Bank Takes $2.81 Million Position in Alumis Inc. $ALMS - MarketBeat
Stempoint Capital LP Buys New Stake in Alumis Inc. $ALMS - MarketBeat
166,959 Shares in Alumis Inc. $ALMS Purchased by Ally Bridge Group NY LLC - MarketBeat
Elmind Capital LP Purchases New Shares in Alumis Inc. $ALMS - MarketBeat
BlackRock, Inc. (ALMS) reports 7.1M-share, 5.7% beneficial stake in Alumis - Stock Titan
Alumis Market Sentiment - Benzinga España
ALMS|Alumis Inc|Price:27.070|Chg%:-0.930 - TradingKey
Orbimed Advisors LLC Has $12.08 Million Stock Holdings in Alumis Inc. $ALMS - MarketBeat
ALMS|Alumis Inc|Price:26.312|Chg%:-0.768 - TradingKey
Alumis Inc (ALMS) Income Statement - tradingkey.com
Alumis Inc (ALMS) Balance Sheet - TradingKey
Alumis Inc (ALMS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Alumis Inc (ALMS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Weiss Asset Management LP Buys New Shares in Alumis Inc. $ALMS - MarketBeat
Alumis Inc (ALMS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
ALMS|Alumis Inc|Price:28.000|Chg%:-0.300 - TradingKey
Alumis Inc. Revenue Breakdown – NASDAQ:ALMS - tradingview.com
Spruce Street Capital LP Buys Shares of 392,574 Alumis Inc. $ALMS - MarketBeat
Alumis Inc (ALMS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Principal Financial Group Inc. Acquires Shares of 1,058,051 Alumis Inc. $ALMS - MarketBeat
Alumis Inc. $ALMS Shares Sold by Towerview LLC - marketbeat.com
(ALMS) Volatility Zones as Tactical Triggers - Stock Traders Daily
0.86%
0.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):